Effects of Cultura Yoghurt in Relation to Transit Time and Digestive Discomfort in Healthy Women and Men
NCT ID: NCT01102036
Last Updated: 2011-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2010-02-28
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exploring the Potential Benefits of Probiotic Yogurt
NCT06847919
Efficacy Evaluation of Probiotic Product on Bowel Habits in Healthy Subjects
NCT01375712
Effects of Probiotic Supplementation on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Constipation.
NCT02189707
The Effect of Probiotic Supported Yogurt Consumption on Gastrointestinal Symptoms
NCT05566171
Study of the Effect of a Fermented Dairy Product on Gastrointestinal Well Being in Adult Women
NCT01388010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* determine the effect on mean transit time after 2 weeks intake of a investigational products using radio-opaque sulphate impregnated polyethylene pellets as markers.
* determine effect of investigational products on total symptom score according to Bristol Stool Form (BSF)
* determine effect of investigational products in gastrointestinal symptoms
* determine safety of intake of the investigational products
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Yoghurt without probiotics
Yoghurt without probiotic bacteria
Yoghurt without probiotics
Yoghurt without probiotics
Cultura yoghurt
Cultura yoghurt with L casei F19, acidophilus La5 adn B lactis Bb 12
Cultura L casei F19, acidophilus La5 , B lactis Bb 12
2 weeks consumption,250 ml/day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cultura L casei F19, acidophilus La5 , B lactis Bb 12
2 weeks consumption,250 ml/day
Yoghurt without probiotics
Yoghurt without probiotics
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy
* BMI 19-29 at visit 1
* Age 18 and 60 years at visit 1
* Defecation 3-4 times per week or every second to third day (Bristol Stool Form) during the run-in
* Transit time 35 and 72 hours calculated from the abdominal X-ray at visit 3
* Signed written informed consent
Exclusion Criteria
* Past history of digestive disease
* Previous complicated GI surgery
* Oral use of antimicrobial medication or antimicrobial prophylaxis 4 weeks prior to screening visit
* Use of laxatives (medication or dietary supplements) during the study.
* Pregnant or lactating or wish to become pregnant during the period of the study
* Lack of suitability for participation in the trial, for any reason, as judged by the personnel at KPL Good Food Practice AB
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arla Foods
INDUSTRY
Good Food Practice, Sweden
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Birgitta Sundberg
Director clinical trials
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars Magnusson, CEO
Role: STUDY_DIRECTOR
Good Food Practice, Uppsala, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Good Food Practice
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-X-Ray U-09-017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.